The following schedule summarizes the non-cash investing and financing activities of the Company for the three months ended March 31, 2026 and 2025 (in thousands):


	Three Months Ended March 31,
	2026			2025
Proceeds deposited in escrow through sale of real estate interests	$	561		$	-
Capital expenditures accrual	$	48,852		$	48,419
Lease liabilities arising from obtaining operating right-of-use assets	$	1,424		$	-
Decrease in redeemable noncontrolling interests’ carrying amount, net	$	(3,714	)	$	(577	)
Surrender of restricted common stock/units	$	6,042		$	11,536
Declaration of dividends/distributions paid in succeeding period	$	6,364		$	6,373

The following table provides a reconciliation of cash, cash equivalents and restricted cash recorded on the Company’s Condensed Consolidated Balance Sheets to the Company’s Condensed Consolidated Statements of Cash Flows (in thousands):


	As of March 31, 2026		As of December 31, 2025
Cash and cash equivalents	$	168,438	$	211,648
Restricted cash		1,165		1,146
Total cash, cash equivalents and restricted cash	$	169,603	$	212,794